MedTrace Logo

Statin Therapy to Improve Medication Adherence

NCT01894217 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2015-01-08

No results posted yet for this study

Summary

The purpose of this pilot study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects with statins. This study will assist physicians in making a personalized health care plan for prevention of cardiovascular disease.

Conditions

Interventions

GENETIC

Genetic testing and reporting for SLCO1B1*5 allele

Blood test for SLCO1B1\*5 allele; reporting of test results to provider and participant

Sponsors & Collaborators

Principal Investigators

  • Deepak Voora, MD · Duke University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01894217 on ClinicalTrials.gov